Global (United States, European Union and China) Enteric Softgel Capsules
Global (United States, European Union and China) Enteric Softgel Capsules

Enteric Softgel Capsules Comprehensive Study by Type (Gelatin enteric soft gel capsules, Non-gelatin enteric soft gel capsules), Application (Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Others), End Users (Health supplements, Pharmaceuticals), Distribution Channel (Online, Offline), Coating Compositions (Methacrylic acid, Acrylate copolymer, Others) Players and Region - Global Market Outlook to 2026

Enteric Softgel Capsules Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 237 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Enteric Softgel Capsules?
Softgel capsules are an oral dosage form for medicine that contains a pharmaceutical liquid enclosed by a gelatin-based shell. Enteric soft gel capsules are coated with polymers such as cellulose, vinyl, and acrylic derivatives. Enteric release coatings applied to nutritional tablets or soft gels improve consumer appeal. They help reduce unpleasant flavors and odors because the food additive is not released in the stomach; it is released in the small intestine instead. Our nutritional enteric coating systems are an excellent option for both tablets and soft gelatin capsules. The key driving factors of boosting demand for enteric soft gel capsules are the escalation of R&D activities directed towards improving the bioavailability of new drugs

The market study is broken down by Type (Gelatin enteric soft gel capsules and Non-gelatin enteric soft gel capsules), by Application (Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Enteric Softgel Capsules market throughout the predicted period.

Catalent(United States), Sirio Pharma (China), Aenova Group GmbH (Germany), ProCaps Laboratories (United States), InovoBiologic(Canada), Dart Neuroscience (United States), Lonza (Switzerland), NutraNorth (Canada) and Nature’s Way Products, LLC. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Salmon Pharma GmbH (Germany).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Enteric Softgel Capsules market by Type, Application and Region.

On the basis of geography, the market of Enteric Softgel Capsules has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Health supplements will boost the Enteric Softgel Capsules market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Enteric Softgel Capsules market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Coating Compositions, the sub-segment i.e. Methacrylic acid will boost the Enteric Softgel Capsules market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In October 2020 Catalent The drug delivery innovation significant launches Softgel for Pharmaceutical and Nutraceutical Applications, named as OptiGel DR, a delayed /enteric delivery Softgel. Catalent, the main worldwide supplier of cutting edge conveyance advances, improvement, and assembling answers for drugs, biologics, cell, and quality treatments, and purchaser wellbeing items, declared the dispatch of OptiGel DR innovation for the detailing and production of postponed/enteric delivery softgels. The innovation permits softgel cases to be framed by consolidating gelatin, a normally determined polysaccharide, with gelatin, wiping out the requirement for a different case covering step.


Market Trend
  • Rise in the promotional activities by manufacturers

Market Drivers
  • The rise in adoption of enteric softgel
  • The shifting focus of the manufacturers for manufacturing the enteric soft gel capsules using non-gelatin ingredients to cater to the increasing demand from the vegetarian consumer base across the globe.

Opportunities
  • Enteric Softgel Capsules are currently being applied widely in the pharmaceutical, chemical, food, and cosmetic industry

Restraints
  • Stringent regulations on the adoption of enteric soft gel capsules due to its shelf-life stability problems

Challenges
  • Shelf-life Stability Concerns Create Major Challenges


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Enteric Softgel Capsules Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Gelatin enteric soft gel capsules
  • Non-gelatin enteric soft gel capsules
By Application
  • Antacid and Antiflatulent Preparations
  • Antibiotic and Antibacterial Drugs
  • Others
By End Users
  • Health supplements
  • Pharmaceuticals

By Distribution Channel
  • Online
  • Offline

By Coating Compositions
  • Methacrylic acid
  • Acrylate copolymer
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The rise in adoption of enteric softgel
      • 3.2.2. The shifting focus of the manufacturers for manufacturing the enteric soft gel capsules using non-gelatin ingredients to cater to the increasing demand from the vegetarian consumer base across the globe.
    • 3.3. Market Challenges
      • 3.3.1. Shelf-life Stability Concerns Create Major Challenges
    • 3.4. Market Trends
      • 3.4.1. Rise in the promotional activities by manufacturers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Enteric Softgel Capsules, by Type, Application, End Users, Distribution Channel, Coating Compositions and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Enteric Softgel Capsules (Value)
      • 5.2.1. Global Enteric Softgel Capsules by: Type (Value)
        • 5.2.1.1. Gelatin enteric soft gel capsules
        • 5.2.1.2. Non-gelatin enteric soft gel capsules
      • 5.2.2. Global Enteric Softgel Capsules by: Application (Value)
        • 5.2.2.1. Antacid and Antiflatulent Preparations
        • 5.2.2.2. Antibiotic and Antibacterial Drugs
        • 5.2.2.3. Others
      • 5.2.3. Global Enteric Softgel Capsules by: End Users (Value)
        • 5.2.3.1. Health supplements
        • 5.2.3.2. Pharmaceuticals
      • 5.2.4. Global Enteric Softgel Capsules by: Distribution Channel (Value)
        • 5.2.4.1. Online
        • 5.2.4.2. Offline
      • 5.2.5. Global Enteric Softgel Capsules by: Coating Compositions (Value)
        • 5.2.5.1. Methacrylic acid
        • 5.2.5.2. Acrylate copolymer
        • 5.2.5.3. Others
      • 5.2.6. Global Enteric Softgel Capsules Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Enteric Softgel Capsules (Volume)
      • 5.3.1. Global Enteric Softgel Capsules by: Type (Volume)
        • 5.3.1.1. Gelatin enteric soft gel capsules
        • 5.3.1.2. Non-gelatin enteric soft gel capsules
      • 5.3.2. Global Enteric Softgel Capsules by: Application (Volume)
        • 5.3.2.1. Antacid and Antiflatulent Preparations
        • 5.3.2.2. Antibiotic and Antibacterial Drugs
        • 5.3.2.3. Others
      • 5.3.3. Global Enteric Softgel Capsules by: End Users (Volume)
        • 5.3.3.1. Health supplements
        • 5.3.3.2. Pharmaceuticals
      • 5.3.4. Global Enteric Softgel Capsules by: Distribution Channel (Volume)
        • 5.3.4.1. Online
        • 5.3.4.2. Offline
      • 5.3.5. Global Enteric Softgel Capsules by: Coating Compositions (Volume)
        • 5.3.5.1. Methacrylic acid
        • 5.3.5.2. Acrylate copolymer
        • 5.3.5.3. Others
      • 5.3.6. Global Enteric Softgel Capsules Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Enteric Softgel Capsules (Price)
      • 5.4.1. Global Enteric Softgel Capsules by: Type (Price)
  • 6. Enteric Softgel Capsules: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Catalent(United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sirio Pharma (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aenova Group GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ProCaps Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. InovoBiologic(Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dart Neuroscience (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lonza (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. NutraNorth (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nature’s Way Products, LLC. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Enteric Softgel Capsules Sale, by Type, Application, End Users, Distribution Channel, Coating Compositions and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Enteric Softgel Capsules (Value)
      • 7.2.1. Global Enteric Softgel Capsules by: Type (Value)
        • 7.2.1.1. Gelatin enteric soft gel capsules
        • 7.2.1.2. Non-gelatin enteric soft gel capsules
      • 7.2.2. Global Enteric Softgel Capsules by: Application (Value)
        • 7.2.2.1. Antacid and Antiflatulent Preparations
        • 7.2.2.2. Antibiotic and Antibacterial Drugs
        • 7.2.2.3. Others
      • 7.2.3. Global Enteric Softgel Capsules by: End Users (Value)
        • 7.2.3.1. Health supplements
        • 7.2.3.2. Pharmaceuticals
      • 7.2.4. Global Enteric Softgel Capsules by: Distribution Channel (Value)
        • 7.2.4.1. Online
        • 7.2.4.2. Offline
      • 7.2.5. Global Enteric Softgel Capsules by: Coating Compositions (Value)
        • 7.2.5.1. Methacrylic acid
        • 7.2.5.2. Acrylate copolymer
        • 7.2.5.3. Others
      • 7.2.6. Global Enteric Softgel Capsules Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Enteric Softgel Capsules (Volume)
      • 7.3.1. Global Enteric Softgel Capsules by: Type (Volume)
        • 7.3.1.1. Gelatin enteric soft gel capsules
        • 7.3.1.2. Non-gelatin enteric soft gel capsules
      • 7.3.2. Global Enteric Softgel Capsules by: Application (Volume)
        • 7.3.2.1. Antacid and Antiflatulent Preparations
        • 7.3.2.2. Antibiotic and Antibacterial Drugs
        • 7.3.2.3. Others
      • 7.3.3. Global Enteric Softgel Capsules by: End Users (Volume)
        • 7.3.3.1. Health supplements
        • 7.3.3.2. Pharmaceuticals
      • 7.3.4. Global Enteric Softgel Capsules by: Distribution Channel (Volume)
        • 7.3.4.1. Online
        • 7.3.4.2. Offline
      • 7.3.5. Global Enteric Softgel Capsules by: Coating Compositions (Volume)
        • 7.3.5.1. Methacrylic acid
        • 7.3.5.2. Acrylate copolymer
        • 7.3.5.3. Others
      • 7.3.6. Global Enteric Softgel Capsules Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Enteric Softgel Capsules (Price)
      • 7.4.1. Global Enteric Softgel Capsules by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Enteric Softgel Capsules: by Type(USD Million)
  • Table 2. Enteric Softgel Capsules Gelatin enteric soft gel capsules , by Region USD Million (2015-2020)
  • Table 3. Enteric Softgel Capsules Non-gelatin enteric soft gel capsules , by Region USD Million (2015-2020)
  • Table 4. Enteric Softgel Capsules: by Application(USD Million)
  • Table 5. Enteric Softgel Capsules Antacid and Antiflatulent Preparations , by Region USD Million (2015-2020)
  • Table 6. Enteric Softgel Capsules Antibiotic and Antibacterial Drugs , by Region USD Million (2015-2020)
  • Table 7. Enteric Softgel Capsules Others , by Region USD Million (2015-2020)
  • Table 8. Enteric Softgel Capsules: by End Users(USD Million)
  • Table 9. Enteric Softgel Capsules Health supplements , by Region USD Million (2015-2020)
  • Table 10. Enteric Softgel Capsules Pharmaceuticals , by Region USD Million (2015-2020)
  • Table 11. Enteric Softgel Capsules: by Distribution Channel(USD Million)
  • Table 12. Enteric Softgel Capsules Online , by Region USD Million (2015-2020)
  • Table 13. Enteric Softgel Capsules Offline , by Region USD Million (2015-2020)
  • Table 14. Enteric Softgel Capsules: by Coating Compositions(USD Million)
  • Table 15. Enteric Softgel Capsules Methacrylic acid , by Region USD Million (2015-2020)
  • Table 16. Enteric Softgel Capsules Acrylate copolymer , by Region USD Million (2015-2020)
  • Table 17. Enteric Softgel Capsules Others , by Region USD Million (2015-2020)
  • Table 18. South America Enteric Softgel Capsules, by Country USD Million (2015-2020)
  • Table 19. South America Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 20. South America Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 21. South America Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 22. South America Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 23. South America Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 24. Brazil Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 25. Brazil Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 26. Brazil Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 27. Brazil Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 28. Brazil Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 29. Argentina Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 30. Argentina Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 31. Argentina Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 32. Argentina Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 33. Argentina Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 34. Rest of South America Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 36. Rest of South America Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 37. Rest of South America Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 38. Rest of South America Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 39. Asia Pacific Enteric Softgel Capsules, by Country USD Million (2015-2020)
  • Table 40. Asia Pacific Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 41. Asia Pacific Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 42. Asia Pacific Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 43. Asia Pacific Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 44. Asia Pacific Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 45. China Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 46. China Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 47. China Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 48. China Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 49. China Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 50. Japan Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 51. Japan Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 52. Japan Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 53. Japan Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 54. Japan Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 55. India Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 56. India Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 57. India Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 58. India Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 59. India Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 60. South Korea Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 61. South Korea Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 62. South Korea Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 63. South Korea Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 64. South Korea Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 65. Taiwan Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 66. Taiwan Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 67. Taiwan Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 68. Taiwan Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 69. Taiwan Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 70. Australia Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 71. Australia Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 72. Australia Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 73. Australia Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 74. Australia Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 80. Europe Enteric Softgel Capsules, by Country USD Million (2015-2020)
  • Table 81. Europe Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 82. Europe Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 83. Europe Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 84. Europe Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 85. Europe Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 86. Germany Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 87. Germany Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 88. Germany Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 89. Germany Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 90. Germany Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 91. France Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 92. France Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 93. France Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 94. France Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 95. France Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 96. Italy Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 97. Italy Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 98. Italy Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 99. Italy Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 100. Italy Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 101. United Kingdom Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 102. United Kingdom Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 103. United Kingdom Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 104. United Kingdom Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 105. United Kingdom Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 106. Netherlands Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 107. Netherlands Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 108. Netherlands Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 109. Netherlands Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 110. Netherlands Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 111. Rest of Europe Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 112. Rest of Europe Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 113. Rest of Europe Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 114. Rest of Europe Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 115. Rest of Europe Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 116. MEA Enteric Softgel Capsules, by Country USD Million (2015-2020)
  • Table 117. MEA Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 118. MEA Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 119. MEA Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 120. MEA Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 121. MEA Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 122. Middle East Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 123. Middle East Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 124. Middle East Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 125. Middle East Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 126. Middle East Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 127. Africa Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 128. Africa Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 129. Africa Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 130. Africa Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 131. Africa Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 132. North America Enteric Softgel Capsules, by Country USD Million (2015-2020)
  • Table 133. North America Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 134. North America Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 135. North America Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 136. North America Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 137. North America Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 138. United States Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 139. United States Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 140. United States Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 141. United States Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 142. United States Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 143. Canada Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 144. Canada Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 145. Canada Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 146. Canada Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 147. Canada Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 148. Mexico Enteric Softgel Capsules, by Type USD Million (2015-2020)
  • Table 149. Mexico Enteric Softgel Capsules, by Application USD Million (2015-2020)
  • Table 150. Mexico Enteric Softgel Capsules, by End Users USD Million (2015-2020)
  • Table 151. Mexico Enteric Softgel Capsules, by Distribution Channel USD Million (2015-2020)
  • Table 152. Mexico Enteric Softgel Capsules, by Coating Compositions USD Million (2015-2020)
  • Table 153. Enteric Softgel Capsules Sales: by Type(K Units)
  • Table 154. Enteric Softgel Capsules Sales Gelatin enteric soft gel capsules , by Region K Units (2015-2020)
  • Table 155. Enteric Softgel Capsules Sales Non-gelatin enteric soft gel capsules , by Region K Units (2015-2020)
  • Table 156. Enteric Softgel Capsules Sales: by Application(K Units)
  • Table 157. Enteric Softgel Capsules Sales Antacid and Antiflatulent Preparations , by Region K Units (2015-2020)
  • Table 158. Enteric Softgel Capsules Sales Antibiotic and Antibacterial Drugs , by Region K Units (2015-2020)
  • Table 159. Enteric Softgel Capsules Sales Others , by Region K Units (2015-2020)
  • Table 160. Enteric Softgel Capsules Sales: by End Users(K Units)
  • Table 161. Enteric Softgel Capsules Sales Health supplements , by Region K Units (2015-2020)
  • Table 162. Enteric Softgel Capsules Sales Pharmaceuticals , by Region K Units (2015-2020)
  • Table 163. Enteric Softgel Capsules Sales: by Distribution Channel(K Units)
  • Table 164. Enteric Softgel Capsules Sales Online , by Region K Units (2015-2020)
  • Table 165. Enteric Softgel Capsules Sales Offline , by Region K Units (2015-2020)
  • Table 166. Enteric Softgel Capsules Sales: by Coating Compositions(K Units)
  • Table 167. Enteric Softgel Capsules Sales Methacrylic acid , by Region K Units (2015-2020)
  • Table 168. Enteric Softgel Capsules Sales Acrylate copolymer , by Region K Units (2015-2020)
  • Table 169. Enteric Softgel Capsules Sales Others , by Region K Units (2015-2020)
  • Table 170. South America Enteric Softgel Capsules Sales, by Country K Units (2015-2020)
  • Table 171. South America Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 172. South America Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 173. South America Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 174. South America Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 175. South America Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 176. Brazil Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 177. Brazil Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 178. Brazil Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 179. Brazil Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 180. Brazil Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 181. Argentina Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 182. Argentina Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 183. Argentina Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 184. Argentina Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 185. Argentina Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 186. Rest of South America Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 187. Rest of South America Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 188. Rest of South America Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 189. Rest of South America Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 190. Rest of South America Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 191. Asia Pacific Enteric Softgel Capsules Sales, by Country K Units (2015-2020)
  • Table 192. Asia Pacific Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 193. Asia Pacific Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 194. Asia Pacific Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 195. Asia Pacific Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 196. Asia Pacific Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 197. China Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 198. China Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 199. China Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 200. China Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 201. China Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 202. Japan Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 203. Japan Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 204. Japan Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 205. Japan Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 206. Japan Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 207. India Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 208. India Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 209. India Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 210. India Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 211. India Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 212. South Korea Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 213. South Korea Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 214. South Korea Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 215. South Korea Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 216. South Korea Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 217. Taiwan Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 218. Taiwan Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 219. Taiwan Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 220. Taiwan Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 221. Taiwan Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 222. Australia Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 223. Australia Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 224. Australia Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 225. Australia Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 226. Australia Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 227. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 228. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 229. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 230. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 231. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 232. Europe Enteric Softgel Capsules Sales, by Country K Units (2015-2020)
  • Table 233. Europe Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 234. Europe Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 235. Europe Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 236. Europe Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 237. Europe Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 238. Germany Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 239. Germany Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 240. Germany Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 241. Germany Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 242. Germany Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 243. France Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 244. France Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 245. France Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 246. France Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 247. France Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 248. Italy Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 249. Italy Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 250. Italy Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 251. Italy Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 252. Italy Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 253. United Kingdom Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 254. United Kingdom Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 255. United Kingdom Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 256. United Kingdom Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 257. United Kingdom Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 258. Netherlands Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 259. Netherlands Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 260. Netherlands Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 261. Netherlands Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 262. Netherlands Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 263. Rest of Europe Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 264. Rest of Europe Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 265. Rest of Europe Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 266. Rest of Europe Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 267. Rest of Europe Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 268. MEA Enteric Softgel Capsules Sales, by Country K Units (2015-2020)
  • Table 269. MEA Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 270. MEA Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 271. MEA Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 272. MEA Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 273. MEA Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 274. Middle East Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 275. Middle East Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 276. Middle East Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 277. Middle East Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 278. Middle East Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 279. Africa Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 280. Africa Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 281. Africa Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 282. Africa Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 283. Africa Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 284. North America Enteric Softgel Capsules Sales, by Country K Units (2015-2020)
  • Table 285. North America Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 286. North America Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 287. North America Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 288. North America Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 289. North America Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 290. United States Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 291. United States Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 292. United States Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 293. United States Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 294. United States Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 295. Canada Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 296. Canada Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 297. Canada Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 298. Canada Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 299. Canada Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 300. Mexico Enteric Softgel Capsules Sales, by Type K Units (2015-2020)
  • Table 301. Mexico Enteric Softgel Capsules Sales, by Application K Units (2015-2020)
  • Table 302. Mexico Enteric Softgel Capsules Sales, by End Users K Units (2015-2020)
  • Table 303. Mexico Enteric Softgel Capsules Sales, by Distribution Channel K Units (2015-2020)
  • Table 304. Mexico Enteric Softgel Capsules Sales, by Coating Compositions K Units (2015-2020)
  • Table 305. Enteric Softgel Capsules: by Type(USD/Units)
  • Table 306. Company Basic Information, Sales Area and Its Competitors
  • Table 307. Company Basic Information, Sales Area and Its Competitors
  • Table 308. Company Basic Information, Sales Area and Its Competitors
  • Table 309. Company Basic Information, Sales Area and Its Competitors
  • Table 310. Company Basic Information, Sales Area and Its Competitors
  • Table 311. Company Basic Information, Sales Area and Its Competitors
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Enteric Softgel Capsules: by Type(USD Million)
  • Table 316. Enteric Softgel Capsules Gelatin enteric soft gel capsules , by Region USD Million (2021-2026)
  • Table 317. Enteric Softgel Capsules Non-gelatin enteric soft gel capsules , by Region USD Million (2021-2026)
  • Table 318. Enteric Softgel Capsules: by Application(USD Million)
  • Table 319. Enteric Softgel Capsules Antacid and Antiflatulent Preparations , by Region USD Million (2021-2026)
  • Table 320. Enteric Softgel Capsules Antibiotic and Antibacterial Drugs , by Region USD Million (2021-2026)
  • Table 321. Enteric Softgel Capsules Others , by Region USD Million (2021-2026)
  • Table 322. Enteric Softgel Capsules: by End Users(USD Million)
  • Table 323. Enteric Softgel Capsules Health supplements , by Region USD Million (2021-2026)
  • Table 324. Enteric Softgel Capsules Pharmaceuticals , by Region USD Million (2021-2026)
  • Table 325. Enteric Softgel Capsules: by Distribution Channel(USD Million)
  • Table 326. Enteric Softgel Capsules Online , by Region USD Million (2021-2026)
  • Table 327. Enteric Softgel Capsules Offline , by Region USD Million (2021-2026)
  • Table 328. Enteric Softgel Capsules: by Coating Compositions(USD Million)
  • Table 329. Enteric Softgel Capsules Methacrylic acid , by Region USD Million (2021-2026)
  • Table 330. Enteric Softgel Capsules Acrylate copolymer , by Region USD Million (2021-2026)
  • Table 331. Enteric Softgel Capsules Others , by Region USD Million (2021-2026)
  • Table 332. South America Enteric Softgel Capsules, by Country USD Million (2021-2026)
  • Table 333. South America Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 334. South America Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 335. South America Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 336. South America Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 337. South America Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 338. Brazil Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 339. Brazil Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 340. Brazil Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 341. Brazil Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 342. Brazil Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 343. Argentina Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 344. Argentina Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 345. Argentina Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 346. Argentina Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 347. Argentina Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 348. Rest of South America Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 349. Rest of South America Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 350. Rest of South America Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 351. Rest of South America Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 352. Rest of South America Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 353. Asia Pacific Enteric Softgel Capsules, by Country USD Million (2021-2026)
  • Table 354. Asia Pacific Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 355. Asia Pacific Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 356. Asia Pacific Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 357. Asia Pacific Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 358. Asia Pacific Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 359. China Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 360. China Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 361. China Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 362. China Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 363. China Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 364. Japan Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 365. Japan Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 366. Japan Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 367. Japan Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 368. Japan Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 369. India Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 370. India Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 371. India Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 372. India Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 373. India Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 374. South Korea Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 375. South Korea Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 376. South Korea Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 377. South Korea Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 378. South Korea Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 379. Taiwan Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 380. Taiwan Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 381. Taiwan Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 382. Taiwan Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 383. Taiwan Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 384. Australia Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 385. Australia Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 386. Australia Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 387. Australia Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 388. Australia Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 389. Rest of Asia-Pacific Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 390. Rest of Asia-Pacific Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 391. Rest of Asia-Pacific Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 392. Rest of Asia-Pacific Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 393. Rest of Asia-Pacific Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 394. Europe Enteric Softgel Capsules, by Country USD Million (2021-2026)
  • Table 395. Europe Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 396. Europe Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 397. Europe Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 398. Europe Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 399. Europe Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 400. Germany Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 401. Germany Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 402. Germany Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 403. Germany Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 404. Germany Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 405. France Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 406. France Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 407. France Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 408. France Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 409. France Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 410. Italy Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 411. Italy Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 412. Italy Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 413. Italy Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 414. Italy Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 415. United Kingdom Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 416. United Kingdom Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 417. United Kingdom Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 418. United Kingdom Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 419. United Kingdom Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 420. Netherlands Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 421. Netherlands Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 422. Netherlands Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 423. Netherlands Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 424. Netherlands Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 425. Rest of Europe Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 426. Rest of Europe Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 427. Rest of Europe Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 428. Rest of Europe Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 429. Rest of Europe Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 430. MEA Enteric Softgel Capsules, by Country USD Million (2021-2026)
  • Table 431. MEA Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 432. MEA Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 433. MEA Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 434. MEA Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 435. MEA Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 436. Middle East Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 437. Middle East Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 438. Middle East Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 439. Middle East Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 440. Middle East Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 441. Africa Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 442. Africa Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 443. Africa Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 444. Africa Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 445. Africa Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 446. North America Enteric Softgel Capsules, by Country USD Million (2021-2026)
  • Table 447. North America Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 448. North America Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 449. North America Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 450. North America Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 451. North America Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 452. United States Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 453. United States Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 454. United States Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 455. United States Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 456. United States Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 457. Canada Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 458. Canada Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 459. Canada Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 460. Canada Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 461. Canada Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 462. Mexico Enteric Softgel Capsules, by Type USD Million (2021-2026)
  • Table 463. Mexico Enteric Softgel Capsules, by Application USD Million (2021-2026)
  • Table 464. Mexico Enteric Softgel Capsules, by End Users USD Million (2021-2026)
  • Table 465. Mexico Enteric Softgel Capsules, by Distribution Channel USD Million (2021-2026)
  • Table 466. Mexico Enteric Softgel Capsules, by Coating Compositions USD Million (2021-2026)
  • Table 467. Enteric Softgel Capsules Sales: by Type(K Units)
  • Table 468. Enteric Softgel Capsules Sales Gelatin enteric soft gel capsules , by Region K Units (2021-2026)
  • Table 469. Enteric Softgel Capsules Sales Non-gelatin enteric soft gel capsules , by Region K Units (2021-2026)
  • Table 470. Enteric Softgel Capsules Sales: by Application(K Units)
  • Table 471. Enteric Softgel Capsules Sales Antacid and Antiflatulent Preparations , by Region K Units (2021-2026)
  • Table 472. Enteric Softgel Capsules Sales Antibiotic and Antibacterial Drugs , by Region K Units (2021-2026)
  • Table 473. Enteric Softgel Capsules Sales Others , by Region K Units (2021-2026)
  • Table 474. Enteric Softgel Capsules Sales: by End Users(K Units)
  • Table 475. Enteric Softgel Capsules Sales Health supplements , by Region K Units (2021-2026)
  • Table 476. Enteric Softgel Capsules Sales Pharmaceuticals , by Region K Units (2021-2026)
  • Table 477. Enteric Softgel Capsules Sales: by Distribution Channel(K Units)
  • Table 478. Enteric Softgel Capsules Sales Online , by Region K Units (2021-2026)
  • Table 479. Enteric Softgel Capsules Sales Offline , by Region K Units (2021-2026)
  • Table 480. Enteric Softgel Capsules Sales: by Coating Compositions(K Units)
  • Table 481. Enteric Softgel Capsules Sales Methacrylic acid , by Region K Units (2021-2026)
  • Table 482. Enteric Softgel Capsules Sales Acrylate copolymer , by Region K Units (2021-2026)
  • Table 483. Enteric Softgel Capsules Sales Others , by Region K Units (2021-2026)
  • Table 484. South America Enteric Softgel Capsules Sales, by Country K Units (2021-2026)
  • Table 485. South America Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 486. South America Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 487. South America Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 488. South America Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 489. South America Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 490. Brazil Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 491. Brazil Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 492. Brazil Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 493. Brazil Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 494. Brazil Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 495. Argentina Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 496. Argentina Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 497. Argentina Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 498. Argentina Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 499. Argentina Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 500. Rest of South America Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 501. Rest of South America Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 502. Rest of South America Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 503. Rest of South America Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 504. Rest of South America Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 505. Asia Pacific Enteric Softgel Capsules Sales, by Country K Units (2021-2026)
  • Table 506. Asia Pacific Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 507. Asia Pacific Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 508. Asia Pacific Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 509. Asia Pacific Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 510. Asia Pacific Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 511. China Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 512. China Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 513. China Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 514. China Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 515. China Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 516. Japan Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 517. Japan Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 518. Japan Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 519. Japan Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 520. Japan Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 521. India Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 522. India Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 523. India Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 524. India Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 525. India Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 526. South Korea Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 527. South Korea Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 528. South Korea Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 529. South Korea Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 530. South Korea Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 531. Taiwan Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 532. Taiwan Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 533. Taiwan Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 534. Taiwan Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 535. Taiwan Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 536. Australia Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 537. Australia Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 538. Australia Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 539. Australia Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 540. Australia Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 541. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 542. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 543. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 544. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 545. Rest of Asia-Pacific Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 546. Europe Enteric Softgel Capsules Sales, by Country K Units (2021-2026)
  • Table 547. Europe Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 548. Europe Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 549. Europe Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 550. Europe Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 551. Europe Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 552. Germany Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 553. Germany Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 554. Germany Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 555. Germany Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 556. Germany Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 557. France Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 558. France Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 559. France Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 560. France Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 561. France Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 562. Italy Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 563. Italy Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 564. Italy Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 565. Italy Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 566. Italy Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 567. United Kingdom Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 568. United Kingdom Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 569. United Kingdom Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 570. United Kingdom Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 571. United Kingdom Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 572. Netherlands Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 573. Netherlands Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 574. Netherlands Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 575. Netherlands Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 576. Netherlands Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 577. Rest of Europe Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 578. Rest of Europe Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 579. Rest of Europe Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 580. Rest of Europe Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 581. Rest of Europe Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 582. MEA Enteric Softgel Capsules Sales, by Country K Units (2021-2026)
  • Table 583. MEA Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 584. MEA Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 585. MEA Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 586. MEA Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 587. MEA Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 588. Middle East Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 589. Middle East Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 590. Middle East Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 591. Middle East Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 592. Middle East Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 593. Africa Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 594. Africa Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 595. Africa Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 596. Africa Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 597. Africa Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 598. North America Enteric Softgel Capsules Sales, by Country K Units (2021-2026)
  • Table 599. North America Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 600. North America Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 601. North America Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 602. North America Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 603. North America Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 604. United States Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 605. United States Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 606. United States Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 607. United States Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 608. United States Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 609. Canada Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 610. Canada Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 611. Canada Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 612. Canada Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 613. Canada Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 614. Mexico Enteric Softgel Capsules Sales, by Type K Units (2021-2026)
  • Table 615. Mexico Enteric Softgel Capsules Sales, by Application K Units (2021-2026)
  • Table 616. Mexico Enteric Softgel Capsules Sales, by End Users K Units (2021-2026)
  • Table 617. Mexico Enteric Softgel Capsules Sales, by Distribution Channel K Units (2021-2026)
  • Table 618. Mexico Enteric Softgel Capsules Sales, by Coating Compositions K Units (2021-2026)
  • Table 619. Enteric Softgel Capsules: by Type(USD/Units)
  • Table 620. Research Programs/Design for This Report
  • Table 621. Key Data Information from Secondary Sources
  • Table 622. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Enteric Softgel Capsules: by Type USD Million (2015-2020)
  • Figure 5. Global Enteric Softgel Capsules: by Application USD Million (2015-2020)
  • Figure 6. Global Enteric Softgel Capsules: by End Users USD Million (2015-2020)
  • Figure 7. Global Enteric Softgel Capsules: by Distribution Channel USD Million (2015-2020)
  • Figure 8. Global Enteric Softgel Capsules: by Coating Compositions USD Million (2015-2020)
  • Figure 9. South America Enteric Softgel Capsules Share (%), by Country
  • Figure 10. Asia Pacific Enteric Softgel Capsules Share (%), by Country
  • Figure 11. Europe Enteric Softgel Capsules Share (%), by Country
  • Figure 12. MEA Enteric Softgel Capsules Share (%), by Country
  • Figure 13. North America Enteric Softgel Capsules Share (%), by Country
  • Figure 14. Global Enteric Softgel Capsules: by Type K Units (2015-2020)
  • Figure 15. Global Enteric Softgel Capsules: by Application K Units (2015-2020)
  • Figure 16. Global Enteric Softgel Capsules: by End Users K Units (2015-2020)
  • Figure 17. Global Enteric Softgel Capsules: by Distribution Channel K Units (2015-2020)
  • Figure 18. Global Enteric Softgel Capsules: by Coating Compositions K Units (2015-2020)
  • Figure 19. South America Enteric Softgel Capsules Share (%), by Country
  • Figure 20. Asia Pacific Enteric Softgel Capsules Share (%), by Country
  • Figure 21. Europe Enteric Softgel Capsules Share (%), by Country
  • Figure 22. MEA Enteric Softgel Capsules Share (%), by Country
  • Figure 23. North America Enteric Softgel Capsules Share (%), by Country
  • Figure 24. Global Enteric Softgel Capsules: by Type USD/Units (2015-2020)
  • Figure 25. Global Enteric Softgel Capsules share by Players 2020 (%)
  • Figure 26. Global Enteric Softgel Capsules share by Players (Top 3) 2020(%)
  • Figure 27. Global Enteric Softgel Capsules share by Players (Top 5) 2020(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Catalent(United States) Revenue, Net Income and Gross profit
  • Figure 30. Catalent(United States) Revenue: by Geography 2020
  • Figure 31. Sirio Pharma (China) Revenue, Net Income and Gross profit
  • Figure 32. Sirio Pharma (China) Revenue: by Geography 2020
  • Figure 33. Aenova Group GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Aenova Group GmbH (Germany) Revenue: by Geography 2020
  • Figure 35. ProCaps Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 36. ProCaps Laboratories (United States) Revenue: by Geography 2020
  • Figure 37. InovoBiologic(Canada) Revenue, Net Income and Gross profit
  • Figure 38. InovoBiologic(Canada) Revenue: by Geography 2020
  • Figure 39. Dart Neuroscience (United States) Revenue, Net Income and Gross profit
  • Figure 40. Dart Neuroscience (United States) Revenue: by Geography 2020
  • Figure 41. Lonza (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Lonza (Switzerland) Revenue: by Geography 2020
  • Figure 43. NutraNorth (Canada) Revenue, Net Income and Gross profit
  • Figure 44. NutraNorth (Canada) Revenue: by Geography 2020
  • Figure 45. Nature’s Way Products, LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Nature’s Way Products, LLC. (United States) Revenue: by Geography 2020
  • Figure 47. Global Enteric Softgel Capsules: by Type USD Million (2021-2026)
  • Figure 48. Global Enteric Softgel Capsules: by Application USD Million (2021-2026)
  • Figure 49. Global Enteric Softgel Capsules: by End Users USD Million (2021-2026)
  • Figure 50. Global Enteric Softgel Capsules: by Distribution Channel USD Million (2021-2026)
  • Figure 51. Global Enteric Softgel Capsules: by Coating Compositions USD Million (2021-2026)
  • Figure 52. South America Enteric Softgel Capsules Share (%), by Country
  • Figure 53. Asia Pacific Enteric Softgel Capsules Share (%), by Country
  • Figure 54. Europe Enteric Softgel Capsules Share (%), by Country
  • Figure 55. MEA Enteric Softgel Capsules Share (%), by Country
  • Figure 56. North America Enteric Softgel Capsules Share (%), by Country
  • Figure 57. Global Enteric Softgel Capsules: by Type K Units (2021-2026)
  • Figure 58. Global Enteric Softgel Capsules: by Application K Units (2021-2026)
  • Figure 59. Global Enteric Softgel Capsules: by End Users K Units (2021-2026)
  • Figure 60. Global Enteric Softgel Capsules: by Distribution Channel K Units (2021-2026)
  • Figure 61. Global Enteric Softgel Capsules: by Coating Compositions K Units (2021-2026)
  • Figure 62. South America Enteric Softgel Capsules Share (%), by Country
  • Figure 63. Asia Pacific Enteric Softgel Capsules Share (%), by Country
  • Figure 64. Europe Enteric Softgel Capsules Share (%), by Country
  • Figure 65. MEA Enteric Softgel Capsules Share (%), by Country
  • Figure 66. North America Enteric Softgel Capsules Share (%), by Country
  • Figure 67. Global Enteric Softgel Capsules: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Catalent(United States)
  • Sirio Pharma (China)
  • Aenova Group GmbH (Germany)
  • ProCaps Laboratories (United States)
  • InovoBiologic(Canada)
  • Dart Neuroscience (United States)
  • Lonza (Switzerland)
  • NutraNorth (Canada)
  • Nature’s Way Products, LLC. (United States)
Additional players considered in the study are as follows:
Salmon Pharma GmbH (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation